Related Experiment Videos
Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response
Martin B A Heemskerk1, Dave L Roelen, Marlies K A Dankers
1Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.
Human Immunology
|December 20, 2005
Summary
Greater human leukocyte antigen (HLA) mismatches in hematopoietic stem cell transplants do not always cause more T cell responses. Thymic selection may limit recognition of highly divergent HLA molecules, impacting transplant strategies.
Area of Science:
- Immunology
- Transplantation immunology
- Molecular immunology
Background:
- CD8+ T cell alloreactivity typically involves recognizing donor human leukocyte antigen (HLA) class I molecules and bound peptides.
- Understanding HLA matching is crucial for successful hematopoietic stem cell transplantation (HSCT).
Purpose of the Study:
- To investigate the predictive value of HLA mismatches on T cell alloreactivity in HSCT.
- To explore the relationship between allelic disparity and cytotoxic T lymphocyte (CTL) responses.
Main Methods:
- Retrospective analysis of 80 HSCT donor/patient pairs.
- Utilized the CTLp assay to measure alloreactivity induction.
- Examined single HLA-A, -B, and -C locus mismatches with varying degrees of allelic differences.
Main Results:
- Contrary to expectations, numerous sequence differences in HLA class I molecules did not consistently elicit an allogeneic CTL response.
- A significant number of cases showed limited or no CTL response despite substantial HLA disparity.
Conclusions:
- Positive thymic selection may create a T cell repertoire that is less capable of recognizing extensively diverged allogeneic HLA molecules.
- Findings suggest a need to refine MHC matching strategies for HSCT and deepen the understanding of T cell-HLA interactions post-transplant.